glp-1 als Dysregulation of IGF-1/GLP-1 signaling in the progression of ALS: potential target activators and influences on neurological dysfunctions | Neurological Sciences GLP-1 Medications – Community Education
Description
Not for human or animal use
Post-marketing surveillance data, pharmacovigilance reports, and thousands of patient accounts tell a different story
GLP-1 Users Want Products to Meet Their Needs About one in three current users say they have come across products marketed specifically for GLP-1 users, and more than half of current users would be more likely to purchase some products if they catered specifically to those on GLP-1 medications
doi:10.1093/ckj/sfae380
In the SURPASS-2 head-to-head trial (Fras et al., NEJM 2021), tirzepatide 15mg reduced body weight 5.5kg more than semaglutide 1mg over 40 weeks in a type 2 diabetes population
For instance, the variant rs9939609 in FTO is related to dietary fat intake and variants in BDNF are related to increased BMI [107,108,109]
